Abiomed Inc. (ABMD)
NASDAQ: ABMD
· Real-Time Price · USD
381.02
0.00 (0.00%)
At close: Dec 21, 2022, 10:00 PM
Abiomed Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Cash & Equivalents | 182.34M | 180.49M | 132.82M | 144.25M | 241.88M | 175.45M | 232.71M | 181.02M | 202.24M | 214.83M |
Short-Term Investments | 638.04M | 663.83M | 625.79M | 524.97M | 408.68M | 347.58M | 350.99M | 305.43M | 330.84M | 212.54M |
Long-Term Investments | 289.06M | 296.24M | 351.94M | 374.17M | 327.49M | 393.5M | 365.74M | 395.09M | 264.15M | 287.94M |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.64M | n/a | 1.5M |
Receivables | 94.47M | 91.1M | 90.61M | 88.95M | 89.57M | 88.64M | 97.18M | 92.99M | 80.91M | 82.08M |
Inventory | 102.24M | 95.37M | 93.98M | 90.2M | 85.99M | 83.66M | 81.06M | 82.45M | 83.21M | 89.28M |
Other Current Assets | 45.71M | 29.56M | 33.28M | 36.63M | 45.37M | 34.54M | 26.03M | 31.8M | 19.42M | 20.96M |
Total Current Assets | 1.06B | 1.06B | 976.47M | 885.01M | 871.49M | 729.87M | 787.97M | 693.69M | 716.62M | 619.69M |
Property-Plant & Equipment | 202.71M | 206.84M | 212.01M | 205.95M | 202.28M | 203.93M | 203.24M | 189.76M | 186.6M | 182.02M |
Goodwill & Intangibles | 123.09M | 123.1M | 122.42M | 124.07M | 125.8M | 126.13M | 126.04M | 123.02M | 131.06M | 127.49M |
Total Long-Term Assets | 633.75M | 643.28M | 696.92M | 707.87M | 658.55M | 728.52M | 706.39M | 734.74M | 611.35M | 629.82M |
Total Assets | 1.7B | 1.7B | 1.67B | 1.59B | 1.53B | 1.46B | 1.49B | 1.43B | 1.33B | 1.25B |
Account Payables | 35.07M | 34.8M | 35.35M | 32.07M | 27.62M | 29.81M | 34.84M | 23.59M | 21.73M | 27.75M |
Deferred Revenue | 25.96M | 23.62M | 26.36M | 24.87M | 24.08M | 24.09M | 24.32M | 21.29M | 21.31M | 19.9M |
Short-Term Debt | n/a | n/a | n/a | 66.67M | 839K | 56.46M | 66.05M | 71.66M | 57.23M | 58.43M |
Other Current Liabilities | 73.03M | 82.34M | 76.75M | 3.19M | 61.48M | 2.76M | 3.76M | 3.85M | 4.94M | 4.3M |
Total Current Liabilities | 134.06M | 140.76M | 138.46M | 126.8M | 114.02M | 113.12M | 128.97M | 120.4M | 105.21M | 110.38M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 22.01M | 25.94M | 30.83M | 32.34M | 30.62M | 36.89M | 34.87M | 42.29M | 36.1M | 33.08M |
Total Long-Term Liabilities | 22.7M | 26.68M | 31.61M | 33.14M | 31.45M | 37.75M | 35.72M | 46.59M | 40.35M | 37.28M |
Total Liabilities | 156.76M | 167.44M | 170.07M | 159.94M | 145.47M | 150.87M | 164.68M | 166.99M | 145.56M | 147.66M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 452K | 456K | 455K | 455K | 455K | 454K | 453K | 452K | 452K | 450K |
Retained Earnings | 1.13B | 1.02B | 964.51M | 904.19M | 858.43M | 801.48M | 828.01M | 771.15M | 709.28M | 647.07M |
Comprehensive Income | -46.65M | -38.27M | -27.16M | -20.49M | -14.56M | -12.21M | -11.45M | -4.17M | -7.2M | -8.54M |
Shareholders Equity | 1.54B | 1.54B | 1.5B | 1.43B | 1.38B | 1.31B | 1.33B | 1.26B | 1.18B | 1.1B |
Total Investments | 927.1M | 960.07M | 977.73M | 899.14M | 736.17M | 741.07M | 716.72M | 700.52M | 594.99M | 500.47M |